Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck.
Rodríguez MO, Rivero TC, del Castillo Bahi R, Muchuli CR, Bilbao MA, Vinageras EN, Alert J, Galainena JJ, Rodríguez E, Gracias E, Mulén B, Wilkinson B, de Armas EL, Pérez K, Pineda I, Frómeta M, Leonard I, Mullens V, Viada C, Luaces P, Torres O, Iznaga N, Crombet T. Rodríguez MO, et al. Among authors: torres o. Cancer Biol Ther. 2010 Mar 1;9(5):343-9. doi: 10.4161/cbt.9.5.10981. Epub 2010 Mar 20. Cancer Biol Ther. 2010. PMID: 20448462 Free article. Clinical Trial.
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
Crombet T, Osorio M, Cruz T, Roca C, del Castillo R, Mon R, Iznaga-Escobar N, Figueredo R, Koropatnick J, Renginfo E, Fernández E, Alvárez D, Torres O, Ramos M, Leonard I, Pérez R, Lage A. Crombet T, et al. Among authors: torres o. J Clin Oncol. 2004 May 1;22(9):1646-54. doi: 10.1200/JCO.2004.03.089. J Clin Oncol. 2004. PMID: 15117987 Clinical Trial.
Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trial.
Ramos TC, Figueredo J, Catala M, González S, Selva JC, Cruz TM, Toledo C, Silva S, Pestano Y, Ramos M, Leonard I, Torres O, Marinello P, Pérez R, Lage A. Ramos TC, et al. Among authors: torres o. Cancer Biol Ther. 2006 Apr;5(4):375-9. doi: 10.4161/cbt.5.4.2522. Epub 2006 Apr 19. Cancer Biol Ther. 2006. PMID: 16575203 Free article. Clinical Trial.
Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer.
Crombet T, Torres L, Neninger E, Catalá M, Solano ME, Perera A, Torres O, Iznaga N, Torres F, Pérez R, Lage A. Crombet T, et al. Among authors: torres o, torres f, torres l. J Immunother. 2003 Mar-Apr;26(2):139-48. doi: 10.1097/00002371-200303000-00006. J Immunother. 2003. PMID: 12616105 Clinical Trial.
Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study.
Crombet T, Torres O, Rodríguez V, Menéndez A, Stevenson A, Ramos M, Torres F, Figueredo R, Veitía I, Iznaga N, Pérez R, Lage A. Crombet T, et al. Among authors: torres o, torres f. Hybridoma. 2001 Apr;20(2):131-6. doi: 10.1089/02724570152057634. Hybridoma. 2001. PMID: 11394532 Clinical Trial.
Multicentre oncology clinical trials in primary health care in Cuba: evaluation of programme implementation in Villa Clara Province, 2010-2020.
Lorenzo G, Ortiz RA, Méndez R, Rodríguez M, Marrero R, de la Barca NDC, Granela MC, Artiles M, Norvel M, Cepeda M, Toledo E, González A, Crespo JC, Torres O, Nieto L, Crombet T, Sánchez L, Lage A. Lorenzo G, et al. Among authors: torres o. BJGP Open. 2022 Sep 28;6(3):BJGPO.2021.0165. doi: 10.3399/BJGPO.2021.0165. Print 2022 Sep. BJGP Open. 2022. PMID: 35379687 Free PMC article.
Treatment of hypercholesterolemia in NIDDM with policosanol.
Torres O, Agramonte AJ, Illnait J, Más Ferreiro R, Fernández L, Fernández JC. Torres O, et al. Diabetes Care. 1995 Mar;18(3):393-7. doi: 10.2337/diacare.18.3.393. Diabetes Care. 1995. PMID: 7555484 Clinical Trial.
99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.
Ramos-Suzarte M, Rodríguez N, Oliva JP, Iznaga-Escobar N, Perera A, Morales A, Gonzalez N, Cordero M, Torres L, Pimentel G, Borrón M, González J, Torres O, Rodríguez T, Pérez R. Ramos-Suzarte M, et al. Among authors: torres o, torres l. J Nucl Med. 1999 May;40(5):768-75. J Nucl Med. 1999. PMID: 10319748 Free article. Clinical Trial.
384 results